Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

9.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.3K
Drug Delivery: Overview01:16

Drug Delivery: Overview

455
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
455
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

19
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
19
Drug Regulation01:25

Drug Regulation

2.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.0K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.1K
Drug Clearance: Overview01:06

Drug Clearance: Overview

190
Drug elimination refers to drug removal from the body, either through urine or bile, by the kidneys or liver, respectively. A pharmacokinetic parameter, drug clearance, measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the drug's concentration in plasma.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
190

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preclinical characterization of EGT710, an oral non-peptidomimetic reversible covalent SARS-CoV-2 main protease inhibitor.

npj drug discovery·2026
Same author

Neutralization of SARS-CoV-2 by IgM-14 via engagement of two distinct spike epitopes.

PLoS pathogens·2026
Same author

Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease Inhibitor.

Journal of medicinal chemistry·2026
Same author

Intracranial injection of genetically modified, mosquito non-transmissible Zika virus: Safety in primates and ramifications for brain tumor therapy.

Cell reports. Medicine·2025
Same author

Author Correction: Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants.

Nature·2025
Same author

A dual-reporter HCoV-OC43 for coronavirus biology and countermeasure development.

Antiviral research·2025

Related Experiment Video

Updated: Oct 8, 2025

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
18:46

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

13.4K

Omicron: a drug developer's perspective.

Fang Flora Fang1, Pei-Yong Shi2

  • 1Abimmune Biopharma, Inc., San Diego, CA, USA.

Emerging Microbes & Infections
|December 24, 2021
PubMed
Summary
This summary is machine-generated.

The SARS-CoV-2 Omicron variant shows 35 spike protein mutations, suggesting significant immune evasion and increased transmissibility. New antiviral drugs are crucial to combat future variants effectively.

Keywords:
COVID19COVID19drugsCOVID19vaccinesOmicron variantsSARS-CoV-2

More Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K
Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles
05:36

Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles

Published on: January 26, 2024

1.5K

Related Experiment Videos

Last Updated: Oct 8, 2025

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
18:46

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

13.4K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K
Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles
05:36

Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles

Published on: January 26, 2024

1.5K

Area of Science:

  • Virology
  • Molecular Biology
  • Epidemiology

Background:

  • The SARS-CoV-2 Omicron variant possesses numerous mutations in its spike protein.
  • Previous studies indicated that viral evolution in immune evasion and transmissibility could undermine vaccine efficacy.
  • The emergence of new variants poses an ongoing threat to global public health.

Purpose of the Study:

  • To annotate mutations in the SARS-CoV-2 Omicron variant's spike protein.
  • To analyze the implications of these mutations for viral properties.
  • To inform the development of strategies against future SARS-CoV-2 variants.

Main Methods:

  • Mutation annotation of 35 specific sites within the Omicron spike protein.
  • Comparative analysis of Omicron variant mutations against previous SARS-CoV-2 strains.
  • Literature review of existing modeling studies on viral evolution and vaccine effectiveness.

Main Results:

  • Identified and annotated 35 mutations in the SARS-CoV-2 Omicron spike protein.
  • Analysis suggests Omicron exhibits significant immune evasion capabilities.
  • The mutation profile indicates a potential for enhanced transmissibility of the Omicron variant.

Conclusions:

  • The Omicron variant's mutations present a substantial challenge to current pandemic control measures, including vaccines.
  • Development of novel antiviral drugs is essential to manage viral spread and prevent resistance.
  • Continued surveillance and research are necessary to address the evolving threat of SARS-CoV-2 variants.